Literature DB >> 3022629

The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome.

L K Nieman, G P Chrousos, E H Oldfield, P C Avgerinos, G B Cutler, D L Loriaux.   

Abstract

We gave a standard dexamethasone suppression test and an ovine corticotropin-releasing hormone (CRH) stimulation test to 41 patients with adrenocorticotrophic hormone (ACTH)-dependent hypercortisolism to determine the efficacy of each test in the differential diagnosis of Cushing's syndrome. Twenty-nine of thirty-three patients with Cushing's disease and 0 of 8 patients with ectopic secretion of ACTH responded to the ovine CRH test with increased levels of cortisol. When a cortisol response was judged as positive for Cushing's disease, the CRH test had a diagnostic sensitivity, specificity, and accuracy of 88%, 100%, and 90%, respectively. Twenty-nine patients with Cushing's disease and 1 patient with ectopic secretion of ACTH responded to the dexamethasone suppression test. A combined-test strategy requiring negative results from both tests to exclude a diagnosis of Cushing's disease yielded superior sensitivity (100%) and diagnostic accuracy (98%). Thus, the ovine CRH test works as well as the standard dexamethasone suppression test in discriminating between Cushing's disease and ectopic ACTH secretion. The diagnostic power of each test is enhanced when the two tests are combined.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022629     DOI: 10.7326/0003-4819-105-6-862

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

Review 1.  Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies.

Authors:  M A Magiakou; G P Chrousos
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

2.  Neurological surgery at the National Institutes of Health.

Authors:  Gautam U Mehta; John D Heiss; John K Park; Ashok R Asthagiri; Kareem A Zaghloul; Russell R Lonser
Journal:  World Neurosurg       Date:  2010-07       Impact factor: 2.104

3.  Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide.

Authors:  J Matte; F Roufosse; P Rocmans; A Schoutens; D Jacobovitz; J Mockel
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

4.  Pancreatic insuloma causing Cushing's syndrome.

Authors:  F Torriani; A Uske; E Temler; F Rey; J Hurlimann; B Delaloye; F Gomez
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

5.  Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.

Authors:  M Boscaro; A Rampazzo; N Sonino; G Merola; M Scanarini; F Mantero
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

6.  The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology.

Authors:  J A Yanovski; G B Cutler; G P Chrousos; L K Nieman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

Review 7.  The ectopic ACTH syndrome.

Authors:  Krystallenia I Alexandraki; Ashley B Grossman
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

8.  Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.

Authors:  T Suda; F Tozawa; I Dobashi; N Horiba; N Ohmori; M Yamakado; M Yamada; H Demura
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology.

Authors:  J A Yanovski; G B Cutler; J L Doppman; D L Miller; G P Chrousos; E H Oldfield; L K Nieman
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

10.  Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncology.

Authors:  Nabeel Y Y Al Brahim; Gloria Rambaldini; Shereen Ezzat; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.